Preventing Prostate Cancer to Bone Metastasis
Links shared publicly online about this topic.
- 1,901total visits
Preventing Prostate Cancer to Bone Metastasis
View full resource at physorg.com
Tags: Cancer, Bone Cancer, Bone Metastasis, Prostate Cancer, Bone, Prostate, Dental, Men's Health
Most Recently Shared on July 13, 2009 at 9:06 am By:
Preventing Prostate Cancer to Bone Metastasis http://tinyurl.com/n29qh4
ODAC rejects expanded use for bone drug in men with prostate cancer | HemOncToday
hemonctoday.com — “The FDA’s Oncologic Drugs Advisory Committee rejected a request from Amgen to allow denosumab to be used as a preventive measure for men w” View full resource at hemonctoday.com
Most Recently Shared on February 9, 2012 at 1:11 pm By:
HemOnc Today Oncology and Health News
ODAC rejects expanded use for bone drug in men with prostate cancer: http://t.co/eFDclp28
Wayne State Research To Shed Light On Bone Metastasis In Prostate Cancer « CBS Detroit
detroit.cbslocal.com — “Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for a project that aims to learn more about the deadly spread of prostate cancer into the bones. News, Sports, Weather, Traffic and the Best of Detroit. CBSDetroit.com” View full resource at detroit.cbslocal.com
Most Recently Shared on January 22, 2012 at 9:39 pm By:
Wayne State Research To Shed Light On Bone Metastasis In Prostate Cancer: Prostate cancer is the most frequent a... http://t.co/2we0aG8W
NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer
news-medical.net — “Prostate cancer is the most frequent and second deadliest cancer men face. A team of Wayne State University researchers recently received $363,660 from the National Cancer Institute of the National Institutes of Health for the project - "Bone-induced c-kit in prostate cancer cells: implications for bone metastasis" - that aims to shed new light on implications for bone metastasis in prostate cancer.” View full resource at news-medical.net
Most Recently Shared on January 21, 2012 at 6:03 am By:
NCI-funded project aims to shed new light on implications for bone metastasis in prostate cancer: Prostate cance... http://t.co/Sj3NZ6o3
Denosumab and Bone-Metastasis-Free Survival In Men With Castration-Resistant Prostate Cancer: Results of a Phase 3, Randomised, Placebo-Controlled Trial - OncologySTAT
oncologystat.com — “Lancet. 2011 Nov 15;[Epub Ahead of Print] - MR Smith, F Saad, R Coleman, N Shore, C Goessl, et al” View full resource at oncologystat.com
Most Recently Shared on December 1, 2011 at 5:29 pm By:
OncologySTAT Oncology and Health Site
Story of the Week: Denosumab and Bone–Metastasis-Free Survival In Advanced Prostate Cancer http://t.co/SvZu9qdW
Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial : The Lancet
thelancet.com — “Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial. By - Prof Matthew R Smith MD, Prof Fred Saa...” View full resource at thelancet.com
Most Recently Shared on November 22, 2011 at 5:23 pm By:
Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab
medicalnewstoday.com — “An international clinical trial has found that treatment with a drug that suppresses the normal breakdown of bone can delay the development of bone metastases in men with prostate cancer. The stud” View full resource at medicalnewstoday.com
Most Recently Shared on November 16, 2011 at 10:06 am By:
Development Of Prostate Cancer Bone Metastasis Delayed By Denosumab http://t.co/1LkhIR3M #prostate
Amgen's XGEVA delays onset of bone metastases in men with prostate cancer
news-medical.net — “Amgen announced today the publication of results from a Phase 3 trial (the '147 study) that evaluated XGEVA (denosumab) for use in preventing or delaying the onset of bone metastases in men with nonmetastatic castration-resistant prostate cancer.” View full resource at news-medical.net
Most Recently Shared on November 16, 2011 at 7:14 am By:
Amgen's XGEVA delays onset of bone metastases in men with prostate cancer: Amgen announced today the publication... http://t.co/VeFqFazS
myOptumHealth Store - Vitamin D 1000 IU - Vitamins & Supplements - Food & Nutrition
shopoptum.com — “Vitamin D helps maintain healthy bones by stimulating the body’s ability to absorb the calcium supplied through your diet or supplements. It also helps the body keep the right amount of calcium and phosphorus in the blood. In addition, Vitamin D may help prevent or alleviate a host of conditions from colon, prostate and breast cancer to psoriasis to the common cold. Consult a health care professional before using this product. Easy-to-swallow soft gelatin capsule Contains 1,000 IU of Vitam” View full resource at shopoptum.com
Most Recently Shared on October 18, 2011 at 9:37 pm By:
In the store: #VitaminD 1000 IU: $6.29. Order today and get FREE SHIPPING. Just use promo code "OPEN" at checkout...http://bit.ly/oRTzhn
Modeling cancer using ecological principles
sciencedaily.com — “The invasion of a new species into an established ecosystem can be directly compared to the steps involved in cancer metastasis. New research uses the Tilman model of competition between invasive species to study the metastasis of prostate cells into bone.” View full resource at sciencedaily.com
Most Recently Shared on October 4, 2011 at 2:46 pm By:
Modeling cancer using ecological principles: http://t.co/LRR2Mdxp via @AddThis
Medical News: MBCS: Newer Bone Drug Questioned Over Cost - in Meeting Coverage, MBCS from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Denosumab (Xgeva) may not be cost-effective for prevention of skeletal-related events in breast cancer with bone metastasis, industry researchers cautioned.” View full resource at medpagetoday.com
Most Recently Shared on September 19, 2011 at 9:26 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
Medical News: MBCS: Newer Bone Drug Questioned Over Cost - http://t.co/KWIwq3LT from @medpagetoday #health #medicine
Medical News: MBCS: Newer Bone Drug Questioned Over Cost - in Meeting Coverage, MBCS from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Denosumab (Xgeva) may not be cost-effective for prevention of skeletal-related events in breast cancer with bone metastasis, industry researchers cautioned.” View full resource at medpagetoday.com
Most Recently Shared on September 11, 2011 at 5:57 pm By:
MBCS: Newer Bone Drug Questioned Over Cost http://t.co/kffgspL
MBCS: Newer Bone Drug Questioned Over Cost - QualityPoint Technologies
qualitypointtech.net — “SAN FRANCISCO (MedPage Today) -- Denosumab (Xgeva) may not be cost-effective for prevention of skeletal-related events in breast cancer with bone metastasis, industry researchers cautioned.” View full resource at qualitypointtech.net
Most Recently Shared on September 11, 2011 at 5:45 pm By:
MBCS: Newer Bone Drug Questioned Over Cost: SAN FRANCISCO (MedPage Today) -- Denosumab (Xgeva) may not be cost-eff... http://t.co/sgRVNSx
Medical News: MBCS: Newer Bone Drug Questioned Over Cost - in Meeting Coverage, MBCS from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- Denosumab (Xgeva) may not be cost-effective for prevention of skeletal-related events in breast cancer with bone metastasis, industry researchers cautioned.” View full resource at medpagetoday.com
Most Recently Shared on September 11, 2011 at 5:13 pm By:
MBCS: Newer Bone Drug Questioned Over Cost http://t.co/gkoMOPl
FDA Grants Fast Track Designation For Alpharadin For Castration Resistant Prostate Cancer In Patients With Bone Metastases
medicalnewstoday.com — “Investigational drug Alpharadin (radium-223 chloride) for the treatment of castration-resistant prostate cancer in patients whose cancer has spread to the bone (bone metastasis) has been granted F” View full resource at medicalnewstoday.com
Most Recently Shared on August 23, 2011 at 9:41 pm By:
john clay mchugh Doctor, Surgeon, Urologist, and Physician
FDA Grants Fast Track Designation For Alpharadin For Castration Resistant Prostate Cancer In Patients With Bone ... http://t.co/AlOz5rE
FDA Grants Fast Track Designation For Alpharadin For Castration Resistant Prostate Cancer In Patients With Bone Metastases
medicalnewstoday.com — “Investigational drug Alpharadin (radium-223 chloride) for the treatment of castration-resistant prostate cancer in patients whose cancer has spread to the bone (bone metastasis) has been granted F” View full resource at medicalnewstoday.com
Most Recently Shared on August 23, 2011 at 8:05 pm By:
FDA Grants Fast Track Designation For Alpharadin For Castration Resistant Prostate Cancer In Patients With Bone ... http://t.co/YGo8udO
Advertisement
